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Piperonylic acid stimulates 
keratinocyte growth and survival by 
activating epidermal growth factor 
receptor (EGFR)
Dohyun Lee1, Jinsun Lim1, Kyung-Chul Woo3 & Kyong-Tai Kim  1,2
Epidermal growth factor (EGF) stimulates cell growth, proliferation, and survival. The biological 
benefits of EGF have been utilized in medical uses for improving wound healing as well as in today’s 
skin cosmetics. EGF has been found in urine, saliva, milk, and plasma, but its efficient isolation remains 
a difficult task. With technical advances, recombinant protein purification technique has been used for 
EGF production. However, the recombinant EGF is still expensive and keeping it with stable activity 
is difficult to be used widely. Thus, a molecule that can mimic the EGF activity would be a useful 
alternative of EGF. Herein, we have discovered that a natural small molecule piperonylic acid shows 
EGF-like activity in HaCaT keratinocytes. Piperonylic acid induced EGF receptor (EGFR) activation and 
resulted in serial activation of the downstream modulators. The activated signaling pathway eventually 
up-regulated gene expression of egr-1, c-fos, c-jun, and c-myc, which are involved in cell growth and 
survival. Moreover, piperonylic acid showed promoting role in keratinocyte growth and survival from 
UVB-induced cellular damages. This study has revealed the EGF-like activity of piperonylic acid and 
proposed that the piperonylic acid could be a promising component for skin wound healing agents or 
cosmetic ingredient.
The epidermal growth factor receptor (EGFR) signaling pathway is one of the most important pathways that 
stimulate epidermal cell growth, proliferation and survival1. The molecular feature of the EGFR signaling 
pathway is the activation of MAPK/ERK, PI3K/AKT, and JAK/STAT pathways2,3. Their activation eventu-
ally promotes gene expression involved in cell growth and survival2,3. Because this signal transduction is 
mitogenic and pro-survival, epidermal growth factor (EGF), the ligand of EGFR, has been used as a cuta-
neous wound healing agent for burns and severe ulcers4–6. Furthermore, these days, EGF has emerged as 
an effective skin cosmetic ingredient as its biological activity and the dermal aging mechanism have been 
unveiled7–10.
The 53-amino acid-long human EGF has been isolated from human urine, saliva, milk, and plasma, but the 
yield was too low11. To solve the low yield problem, chemical synthesis or recombinant protein purification 
techniques have been developed and applied to obtain higher yield of EGF12,13. However, the cost for synthesis 
or purification is still expensive and the quality control in active state made it rather difficult to be used widely. 
Therefore, a stable and safe molecule that can mimic the action of EGF would be useful as an EGF alternative. 
In the present study, we have made efforts to discover active natural small compounds for the aforementioned 
purpose and have found a pepper derived EGF-like small molecule that can activate EGFR and its downstream 
signaling.
Pepper is one of the widely used spices in the world. It has also long been applied to medicinal purposes since 
ancient times and was reported to show multiple biological activities such as anti-cancer, anti-inflammatory, 
anti-bacterial, and anti-oxidant activities14–17. Piperonylic acid is a natural small compound isolated from black 
(Piper nigrum L.) and long (Piper longum L.) peppers18. Two recent studies reported that piperonylic acid showed 
lipoxygenase and intestinal α-glucosidase inhibitory activities as well as anti-oxidant activity19,20. However, its 
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additional biological activity is still poorly understood. Herein, we report a novel biological property of piperonylic 
acid, which is useful for the stimulation of keratinocyte growth and survival signaling pathways via EGFR activation.
Results
EGFR was activated by piperonylic acid. To discover small compounds that were active on EGFR, we 
modified and utilized a biosensor system that was developed as previously reported21–23. The modified biosensor 
system has two EGFP fused SH2 domains that is under the control of EF1α promoter (Supplementary Fig. S1a). 
The modified biosensor protein was well expressed with the expected size in transfected cells and its fluorescence 
was well distributed in the cytosol before EGF stimulation (Fig. 1a and b). We, then, treated 100ng/ml of EGF to 
the cells transfected by the modified biosensor vector or mock vector to validate the modified biosensor system. 
The bright green fluorescent spots were detected well within an hour and accumulated as time passed (Fig. 1b, 
Supplementary Fig. S1b). Moreover, just like the original biosensor system, the modified biosensor was also quite 
sensitive to EGF compared to other Grb2 mediating growth factors21 (Supplementary Fig. S1c). Based on these 
results, we demonstrated that the modified biosensor system was made well to recognize EGF or EGF-like acting 
molecules.
Figure 1. EGFR was activated by piperonylic acid. (a) The modified EGFP-SH2 biosensor protein was well 
expressed with the expected size in transfected A549 cells (expected molecular weight of a duplicate of SH2 
domains is 20 kDa). (b) The modified biosensor system detected EGFR activation shown in bright green 
fluorescent spots. (c) The modified biosensor system recognized EGFR activation upon piperonylic acid 
treatment. (d) Tyrosine phosphorylation of EGFR was increased by piperonylic acid treatment (10 minutes). 
Scale bar, 50 μm. Blue fluorescence represents nucleus.
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Next, we performed pilot screening assays using the modified biosensor system and found that piperonylic 
acid was appeared to be positive. When 100 μM of piperonylic acid was treated to biosensor transfected cells, the 
EGFR activation was detected 6 hours post treatment and was accumulated at 24 hours after treatment (Fig. 1c). 
To validate the activation of EGFR, we immunoprecipitated cell lysate using anti-EGFR antibody and analyzed 
the levels of the tyrosine phosphorylation on EGFR in HaCaT cells. HaCaT cells are keratinocytes that express 
robust EGFR (Supplementary Fig. S2a). When 100 μM of piperonylic acid was treated for 10 minutes, the tyros-
ine phosphorylation of EGFR was increased compared to DMSO control but not as much as when compared 
with 1ng/ml of EGF treatment (Fig. 1d). This suggests that piperonylic acid resulted in tyrosine phosphorylation 
of EGFR but the activity was lower than EGF. Another type of growth factor receptor, fibroblast growth factor 
receptor 2 (FGFR2), was not activated by piperonylic acid treatment (Supplementary Fig. S2b), suggesting that 
piperonylic acid was relatively selective to EGFR.
We additionally examined whether or not the piperonylic acid can interact with EGFR. We performed a 
pull-down assay using HaCaT cell lysate with piperonylic acid-coupled Sepharose-4B (Piperonylic acid-4B) or 
control-4B beads. It was found that EGFR was bound to piperonylic acid-4B but the binding was weakened when 
free piperonylic acid was added for competition (Supplementary Fig. S3a). These data suggest that the interaction 
of piperonylic acid with EGFR might participate in facilitating EGFR activation.
Piperonylic acid-induced EGFR activation resulted in activation of ERK and AKT. ERK and AKT 
are well-known downstream modulators of EGFR signaling pathway24. To examine the effect of piperonylic acid on 
the activation of ERK and AKT, we treated 25 μM and 100 μM of piperonylic acid to HaCaT cells for 10 minutes and 
examined the phosphorylation of ERK and AKT. As a result, when compared with DMSO control, the phospho-
rylation of ERK and AKT by 100 μM of piperonylic acid was increased by 3.3 and 2.1 fold, respectively (Fig. 2a–c). 
We then investigated the ERK and AKT activation by piperonylic acid upon treatment time. Both ERK and AKT 
phosphorylation was increased immediately after 100 μM of piperonylic acid treatment but down-regulated as time 
passed, which was similar to the activation pattern induced by 1ng/ml of EGF (Fig. 2d and e).
Next, to verify that the piperonylic acid-induced ERK and AKT activation was dependent on EGFR activation, 
we pre-incubated cells with an EGFR antagonist AG1478 for 10 minutes and then treated with 100 μM of piperon-
ylic acid for 10 minutes. As a result, the ERK and AKT activation was completely blocked in spite of the treatment 
of piperonylic acid (Fig. 2f). These data demonstrate that the piperonylic acid-induced ERK and AKT activation 
was due to EGFR activation.
Piperonylic acid increased gene expression involved in cell growth and survival. The simul-
taneous ERK and AKT activation promotes gene expression involved in cell growth and survival2,3,24. c-myc, 
c-jun, c-fos, and egr-1 are their well-known target genes regulating cell growth and survival25–27. We examined the 
expression changes of these genes upon piperonylic acid treatment. When 100 μM of piperonylic acid was treated 
to HaCaT cells, c-myc, c-fos, and egr-1 mRNAs were significantly increased and c-jun mRNA showed tendency to 
increase (Fig. 3a). Consistent with the mRNA expression patterns, the protein levels of c-Fos and Egr-1 were also 
increased (Supplementary Fig. S4a). We, then, examined whether or not the increased c-fos and egr-1 expression 
by piperonylic acid can be blocked by antagonizing EGFR activation. We treated 100 μM of piperonylic acid 
or 1ng/ml of EGF to cells for 2 hours in the presence or absence of AG1478. The expression of c-fos and egr-1 
mRNAs were significantly increased by both piperonylc acid and EGF, but these increments were completely 
diminished by AG1478 treatment (Fig. 3b). The protein levels were also shown to be consistent with the mRNA 
levels (Supplementary Fig. S4b). These data suggest that piperonylic acid-induced EGFR activation and its down-
stream signaling pathway resulted in the regulation of the gene expression involved in cell growth and survival.
Piperonylic acid promoted keratinocyte growth and survival. How did the changes of gene expres-
sion by piperonylic acid affect cells physiologically? To answer this question, we investigated the effects of piper-
onylic acid on cell growth and survival. Firstly, we performed cell growth assay with piperonylic acid. Compared 
to the DMSO (vehicle) treatment, 50 μM and 100 μM of piperonylic acid treatment significantly increased the 
growth of HaCaT cells (Fig. 4a). The 1 ng/ml of EGF treatment, which acts as a positive control, also promoted 
cell growth as well (Fig. 4a). We next performed wound healing assay, which is another widely adapted method 
for measuring cell growth and survival28. The wound area closure was significantly facilitated by piperonylic acid 
or EGF during 3 days incubation when compared with the DMSO control (Fig. 4b and c). Moreover, because 
HaCaT cells were skin keratinocytes, we additionally examined whether or not piperonylic acid can recover cell 
viability from UVB-induced damage. The UVB (280–315 nm) photon penetrates epidermal layers, where kerat-
inocytes are the most abundant, and causes cellular damages including oxidative stress, inflammation, and DNA 
damages29. The 35 and 50 mJ/cm2 of UVB irradiation decreased HaCaT cell viability compared to non-irradiated 
cells, but the incubation with piperonylic acid after UVB irradiation significantly rescued the viability (Fig. 4d). 
These data suggest that the activation of EGFR signaling pathway by piperonylic acid eventually promoted HaCaT 
cell growth and survival and recovered cell viability from UVB-induced cellular damages.
Discussion
This study revealed the EGF-like activity of piperonylic acid. It activated ERK and AKT phosphorylation and their 
downstream gene expression via EGFR activation. Moreover, PLCγ1 and STAT3 activation was also accompanied 
with the EGF-like acitivity of piperonylic acid (Fig. 2g). The activated signaling pathway consequently resulted in 
the stimulation of keratinocyte growth and survival (Fig. 5).
EGF at nanomolar or subnanomolar concentration induces EGFR activation and accurately regulates signal 
transduction and gene expression in cells30. The treated concentration of EGF in this study (1 ng/ml) is equal to 
156.3pM based on its molecular weight. Although the 100 μM of piperonylic acid showed significant growth and 
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survival promotion in HaCaT cells, the effects were less than the effect by smaller molar amount of EGF (Fig. 4). 
Moreover, the increase of EGFR activation by 100 μM of piperonylic acid was lower than 1ng/ml of EGF (Fig. 1d). 
Due to the ability of piperonylic acid for activating EGFR was lower than the authentic ligand EGF, higher con-
centration of piperonylic acid might be inevitable to induce EGFR activation. Therefore, we assume that strong 
EGFR activation is considered to be beyond the capability of piperonylic acid.
One possible mechanism for EGFR activation by piperonylic acid is through generation of hydrogen peroxide. 
Recent studies reported that peroxide induces sulfenylation on the catalytic site of EGFR and facilitates its acti-
vation, and that some small compounds can activate EGFR through generating hydrogen peroxide31,32. However, 
100 μM of piperonylic acid did not generate any reactive oxygen species (ROS) (Supplementary Fig. S5). Another 
possible mechanism is through interaction with EGFR. As EGFR interacted with piperonylic acid-coupled 
Sepharose-4B, the direct or indirect binding can promote EGFR activation (Supplementary Fig. S3a). In addi-
tion to the result of the pull-down assay, we found several putative binding pockets for piperonylic acid at the 
Figure 2. Piperonylic acid-induced EGFR activation resulted in activation of the downstream modulators of 
EGFR. (a) Both ERK and AKT were activated by 10 minutes treatment of indicated amounts of piperonylic 
acid in HaCaT cells. (b,c) Quantification of bands densities of P-ERK and P-AKT, respectively (n = 3). All data 
are presented as mean ± SD. Unpaired t-test. *p < 0.05, **p < 0.01. (d,e) Time dependent modulation of ERK 
and AKT phosphorylation by 100 μM of piperonylic acid or 1ng/ml of EGF, respectively, in HaCaT cells. (f) 
Piperonylic acid-induced ERK and AKT activation was blocked by EGFR antagonist AG1478. (g) PLCγ1 and 
STAT3 were activated by treatment of HaCaT cells with 100 μM of piperonylic acid for 10 minutes.
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extracellular region of EGFR33,34 (Supplementary Fig. S3b). Although the predicted binding pockets for pipero-
nylic acid were different from the EGF binding pocket35 (Supplementary Fig. S3c), we guess that the interaction 
may participate in EGFR activation somehow.
EGFR signaling pathway is important to epidermal cell growth and survival1, but it should be regulated prop-
erly because its excessive activation is correlated with cancer36. To cope with aberrant EGFR activation, cells 
intrinsically have down-regulation mechanisms37–40. In the case of the action of piperonylic acid on normal kerat-
inocytes, the intrinsic down-regulation mechanisms seemed to function well even though its activity was quite 
low compared to EGF (Figs 1c and 2d). Therefore, we suppose that piperonylic acid may not alter the intrinsic 
down-regulation mechanisms of EGFR activation.
Although abnormal EGFR activation is detrimental, its moderate activation is beneficial for mediating repair 
of cutaneous wound and epithelial injury41,42. Because piperonylic acid caused mild EGFR activation and showed 
just a small amount of cytotoxicity in HaCaT keratinocytes (Supplementary Fig. S6), it could be effectively uti-
lized for wound healing and skin rejuvenating cosmetic products. The effects of cosmetics for skin should be mild 
because cosmetics are applied for long period of time. Thus, piperonylic acid may be suitable for cosmetics with 
its activity to trigger mild keratinocyte regeneration. The smaller size of piperonylic acid may also be beneficial to 
permeate skin barrier more easily compared to EGF, which is 38.5 times bigger than piperonylic acid. Therefore, 
in conclusion, the EGF-like activity of piperonylic acid could be applied for skin health products and expected to 
be a successful EGF alternative.
Methods
Reagents and Antibodies. Dulbecco’s modified Eagle’s media (DMEM), Fetal bovine serum (FBS), 
Penicillin-Streptomycin, Trypsin-EDTA, Epidermal growth factor (EGF) (Peprotech), Piperonylic acid, 
Tyrphostin AG1478, Cyanogen bromide-activated-Sepharose® 4B, Thiazolyl Blue Tetrazolium Bromide (MTT), 
Hoechst 33342 (Sigma-Aldrich), G418 (Calbiochem), Cell counting kit-8 (CCK-8) (Dojindo), Dako fluorescent 
mounting medium (Dako), CellROX® Green Reagent (Life technologies), α-p-ERK T202/Y204, α-p-AKT S473, 
α-p-PLCγ1 Y783, α-ERK, α-AKT, α-PLCγ1, α-Egr-1 (CST), α-p-Tyr, α-EGFR, α-c-Fos, α-p-STAT3 S727, 
α-STAT3 (SantaCruz), α-FGFR2 (Abcam), α-GAPDH (Millipore), α-Actin (MP biomedicals), α-mouse IgG 
HRP conjugate (Thermo), and α-rabbit IgG HRP conjugate (Promega).
Cell culture. HEK293A, A549, and HaCaT cell lines were cultured in DMEM supplemented with 10% FBS 
and 1% penicillin-streptomycin at 37 °C under 5% CO2 atmosphere. Prior to the treatment of compounds, cells 
were washed three times with phosphate buffered saline (PBS) and incubated in serum free DMEM for 24 hr.
Biosensor assay. Modified biosensor vector was transfected into A549 cells using Neon® transfection sys-
tem (Invitrogen). The transfected cells were grown on glass chips in DMEM supplemented with 10% FBS and 1% 
penicillin-streptomycin for 24 hr. Cells were washed with warm PBS three times and the medium was exchanged 
with serum free DMEM. After 24 hr of serum depletion, cells were treated with compounds or vehicle (0.1% 
DMSO final) and incubated for appropriate time. Then, cells were fixed with 4% paraformaldehyde (PFA) for 
40 min at room temperature (RT) and washed with PBS three times. Nucleus was stained with Hoechst (10 μg/ml) 
Figure 3. Piperonylic acid increased gene expression involved in cell growth and survival. (a) Time dependent 
gene expression changes by piperonylic acid (100 μM) treatment (n = 4). Data are presented as mean ± SEM. 
Unpaired t-test. *p < 0.05, **p < 0.01. (b) c-fos and egr-1 mRNA expression by piperonylic acid or EGF (at 
2 hours post treatment) in the presence or absence of AG1478 (n = 4). Data are presented as mean ± SEM. 
Unpaired t-test. **p < 0.01, ***p < 0.001.
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in PBS for 10 min and washed twice additionally. Cells were finally mounted with Dako fluorescence mounting 
medium. Images were captured using ZEISS fluorescent microscope.
Western blot analysis. Cell lysate was obtained using a cell lysis buffer containing 50 mM Tris pH 7.5, 
150 mM NaCl, 1 mM EDTA, and 1% Triton X-100. 20–30 μg of protein samples were separated by SDS-PAGE on 
10% SDS gels and transferred to nitrocellulose membranes (110 V constant for 90 min, wet transfer). The mem-
branes were labeled with primary antibodies for overnight at 4 °C and then labeled with horse radish peroxidase 
(HRP)-conjugated secondary antibodies. Chemiluminescence images were captured by ImageQuant LAS 4000 
(Fuji).
Piperonylic acid-4B pull-down assay. Piperonylic acid-4B and Control-4B beads were made using 
CNBr-activated Sepharose® 4B (Sigma) according to the manufacturer’s instructions. Briefly, 1.25 mM of piper-
onylic acid or same volume of DMSO was added for coupling with 40 mg of CNBr-activated Sepharose 4B beads. 
For pull-down assay, 1 mg of HaCaT cell lysate was incubated with 30 μl of Control-4B or Piperonylic acid-4B 
bead for overnight at 4 °C. 500 μM of free piperonylic acid was added for competition. The bound protein was 
analyzed by Western blotting.
Immunoprecipitation. Serum depleted HaCaT cells were treated with 100 μM of piperonylic acid or 1ng/
ml of EGF for 10 minutes (same volume of DMSO for negative control). Harvested cells were lysed with cell lysis 
buffer that was previously mentioned. 500 μg of cell lysate was immunoprecipitated using anti-EGFR antibody 
with 25ul of protein-G agarose bead. The precipitated protein was analyzed by Western blotting. For analyzing 
Figure 4. Piperonylic acid promoted keratinocyte growth and survival. (a) HaCaT cell growth was promoted 
by piperonylic acid treatment measured by 24 hour CCK-8 cell growth assays (n = 12). Data are presented as 
mean ± SEM. Unpaired t-test. **p < 0.01, ****p < 0.0001. (b) Piperonylic acid increased healing process after 
the scratching of the confluent HaCaT cells. Scale bar, 250 μm. (c) Summary of measures of the wound healing 
assays (n = 6). Data are presented as mean ± SEM. Two-way ANOVA followed by Tukey’s multiple comparisons 
test. **p < 0.01, ****p < 0.0001. (d) Recovery of cell viability from UVB irradiation damage (n = 12). Data 
are presented as mean ± SEM. One-way ANOVA followed by Tukey’s multiple comparisons test. **p < 0.01, 
****p < 0.0001.
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FGFR2 activation, serum depleted cells were treated with 100 μM of piperonylic or 100ng/ml of FGF7 for 10 min-
utes, and anti-FGFR2 antibody were used for FGFR2 immunoprecipitation.
Real time qRT-PCR. Total RNA was isolated with RibospinTM-II RNA purification kit (GeneAll) according 
to the manufacturer’s instructions. Isolated RNA was reverse transcribed by ImPromTM-II Reverse Transcription 
System (Promega) according to the manufacturer’s instructions. For detection and quantification, the StepOnePlusTM 
Real-Time PCR System (Applied Biosystems) was used. The sequences of the forward and reverse primers were as 
follows: c-jun forward 5′-AATAACACAGAGAGACAGACTTG-3′, reverse 5′-CTTGGATACCCTTGGCTTTAG-3′; 
egr-1 forward 5′-TGACCGCAGAGTCTTTTCCT-3′, reverse 5′-TGGGTTGGTCATGCTCACTA-3′; c-myc for-
ward 5′-TTCGGGTAGTGGAAAACCAG-3′, reverse 5′-CAGCAGCTCGAATTTCTTCC-3′; c-fos forward 
5′-GTGTGTATTGTTCCCAGTGA-3′, reverse 5′-AGTTAATGCTATGAGAAGACTAAGG-3′; β-actin forward 
5′-AGAGCTACGAGCTGCCTGAC-3′, reverse 5′-AGCACTGTGTTGGCGTACAG-3′.
Cell growth assay. 1 × 104 HaCaT cells were plated with DMEM supplemented with 10% FBS and 1% 
penicillin-streptomycin on 96-well plate and were incubated for 24 hr. Following three washes with PBS, the 
medium was exchanged with compound or vehicle containing serum free DMEM (0.1% DMSO final). After 24 hr 
of additional incubation, Cell counting kit-8 (CCK-8) was treated as the manufacturer’s protocol and the optical 
density (OD) was read at 450 nm.
UVB irradiation. 1 × 104 HaCaT cells were plated with DMEM supplemented with 10% FBS and 1% 
penicillin-streptomycin on 96-well plate and incubated for 24 hr. Cells were washed with PBS three times and 
thin layer of PBS was added. Cells were then exposed to UVB light (35 and 50 mJ/cm2) using 312 nm light source 
of CL-1000 (UVP). After UVB irradiation, cells were cultured in serum free DMEM with or without compounds 
for 24 hr. Control cells were identically processed but without UVB irradiation.
Wound healing assay. 2 × 105 HaCaT cells were plated with DMEM supplemented with 10% FBS and 1% 
penicillin-streptomycin on 12-well plate. When cells reached confluence, a straight scratch per well was made using a 
yellow pipette tip. Following three washes with PBS, the medium was exchanged with compound or vehicle containing 
serum free DMEM (0.1% DMSO final). The medium was exchanged everyday just before the image was taken. Images 
were captured using Olympus phase contrast inverted microscope and the wound areas were quantified using ImageJ.
Measure ROS generation. 1 × 104 HaCaT cells were plated with DMEM supplemented with 10% FBS 
and 1% penicillin-streptomycin on 96-well plate and incubated for 24 hr. Following three washes with PBS, the 
medium was exchanged with serum and phenol-red free DMEM and incubated for 24 hr. 10 minutes after com-
pound treatment, 5 μM of CellROX® reagent and 5 μg/ml of Hoechst were treated and incubated for 30 minutes. 
Then, the ROS signal images were captured using Olympus fluorescent microscope.
Figure 5. Diagram of the signaling pathway activated by piperonylic acid. Piperonylic acid induced activation 
of EGFR and its downstream modulators. The activated signaling pathway modulated gene expression and 
promoted cell growth and survival in HaCaT keratinocytes.
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Cell viability (MTT) assay. 5 × 104 HaCaT cells were plated with DMEM supplemented with 10% FBS and 
1% penicillin-streptomycin on 96-well plate and incubated for 24 hr. Cells were washed with PBS three times 
and various concentrations of piperonylic acid were treated (0.1% DMSO final) in serum free DMEM. After 
24 hr and 48 hr of incubation, cells were treated by Thiazolyl Blue Tetrazolium Bromide (MTT) (0.45 mg/ml 
final) and further incubated for 1.5 hr. The formazans were dissolved by 100 μl of DMSO and the OD was read at 
570 nm.
Statistical Analysis. All statistical analyses were performed using GraphPad Prism version 6.0. The signif-
icance of differences was assessed by the unpaired Student’s t–test or one-way ANOVA followed by the Tukey’s 
multiple comparison tests. A p-value of p < 0.05 was considered to represent a significance. All data are presented 
as mean ± SD or SEM.
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